400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / OX Receptor / Seltorexant
CAS No.: 1293281-49-8
Synonyms: JNJ-42847922;MIN-202
Seltorexant is a selective orexin-2 receptor antagonist that has been shown to promote sleep in various species.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03227224 | Depressive Disorder, Major | Phase 2 | Recruiting | January 9, 2019 | - |
NCT03494907 | Healthy | Phase 1 | Completed | - | Belgium ... more >> Clinical Pharmacology Unit Merksem, Belgium, 2170 Collapse << |
NCT03375203 | Insomnia Disorders | Phase 2 | Recruiting | April 24, 2019 | - |
实验方案
技术信息
CAS号 | 1293281-49-8 | 储存条件 |
|
|
分子式 | C21H22FN7O | 运输 | 蓝冰 | |
分子量 | 407.44 | 别名 | JNJ-42847922;MIN-202 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03227224 | Depressive Disorder, Major | Phase 2 | Recruiting | January 9, 2019 | - |
NCT03494907 | Healthy | Phase 1 | Completed | - | Belgium ... more >> Clinical Pharmacology Unit Merksem, Belgium, 2170 Collapse << |
NCT03375203 | Insomnia Disorders | Phase 2 | Recruiting | April 24, 2019 | - |
NCT03682380 | Healthy | Phase 1 | Recruiting | April 30, 2019 | United States, Utah ... more >> PRAHS Recruiting Salt Lake City, Utah, United States, 84124 Collapse << |
NCT03438461 | Healthy | Phase 1 | Completed | - | United States, Utah ... more >> PRAHS Salt Lake City, Utah, United States, 84124 Collapse << |
NCT03321526 | Depressive Disorder, Major | Phase 2 | Recruiting | January 9, 2019 | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网